ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biosimilars & Follow-on-Biologics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-4U2101
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biosimilars Follow on Biologics Market Research Report 2020
BUY CHAPTERS

Biosimilars & Follow-on-Biologics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4U2101
Report
September 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Hospira
Novartis
Celltrion
Biocon Ltd.
Merck Group
Biogen idec Inc.
Genentech (Roche Group)

Biosimilars & Follow-on-Biologics - Market Size

The global market for Biosimilars & Follow-on-Biologics was estimated to be worth US$ 22490 million in 2023 and is forecast to a readjusted size of US$ 52070 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030

Biosimilars & Follow-on-Biologics - Market

Biosimilars & Follow-on-Biologics - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biosimilars & Follow-on-Biologics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biosimilars & Follow-on-Biologics by region & country, by Type, and by Application.
The Biosimilars & Follow-on-Biologics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars & Follow-on-Biologics.
Market Segmentation

Scope of Biosimilars & Follow-on-Biologics - Market Report

Report Metric Details
Report Name Biosimilars & Follow-on-Biologics - Market
Forecasted market size in 2030 US$ 52070 million
CAGR 15.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal Antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Peptide
  • Others
Segment by Application
  • Blood Disorders
  • Oncology Diseases
  • Chronic and Autoimmune Diseases
  • Growth Hormone Deficiencies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group, Biogen idec, Inc., Genentech (Roche Group)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biosimilars & Follow-on-Biologics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biosimilars & Follow-on-Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biosimilars & Follow-on-Biologics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biosimilars & Follow-on-Biologics - Market size in 2030?

Ans: The Biosimilars & Follow-on-Biologics - Market size in 2030 will be US$ 52070 million.

Who are the main players in the Biosimilars & Follow-on-Biologics - Market report?

Ans: The main players in the Biosimilars & Follow-on-Biologics - Market are Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group, Biogen idec, Inc., Genentech (Roche Group)

What are the Application segmentation covered in the Biosimilars & Follow-on-Biologics - Market report?

Ans: The Applications covered in the Biosimilars & Follow-on-Biologics - Market report are Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies, Others

What are the Type segmentation covered in the Biosimilars & Follow-on-Biologics - Market report?

Ans: The Types covered in the Biosimilars & Follow-on-Biologics - Market report are Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide, Others

1 Market Overview
1.1 Biosimilars & Follow-on-Biologics Product Introduction
1.2 Global Biosimilars & Follow-on-Biologics Market Size Forecast
1.3 Biosimilars & Follow-on-Biologics Market Trends & Drivers
1.3.1 Biosimilars & Follow-on-Biologics Industry Trends
1.3.2 Biosimilars & Follow-on-Biologics Market Drivers & Opportunity
1.3.3 Biosimilars & Follow-on-Biologics Market Challenges
1.3.4 Biosimilars & Follow-on-Biologics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biosimilars & Follow-on-Biologics Players Revenue Ranking (2023)
2.2 Global Biosimilars & Follow-on-Biologics Revenue by Company (2019-2024)
2.3 Key Companies Biosimilars & Follow-on-Biologics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biosimilars & Follow-on-Biologics Product Offered
2.5 Key Companies Time to Begin Mass Production of Biosimilars & Follow-on-Biologics
2.6 Biosimilars & Follow-on-Biologics Market Competitive Analysis
2.6.1 Biosimilars & Follow-on-Biologics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biosimilars & Follow-on-Biologics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Growth Hormone
3.1.2 Erythropoietin
3.1.3 Monoclonal Antibodies
3.1.4 Insulin
3.1.5 Interferon
3.1.6 Granulocyte-Colony Stimulating Factor
3.1.7 Peptide
3.1.8 Others
3.2 Global Biosimilars & Follow-on-Biologics Sales Value by Type
3.2.1 Global Biosimilars & Follow-on-Biologics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biosimilars & Follow-on-Biologics Sales Value, by Type (2019-2030)
3.2.3 Global Biosimilars & Follow-on-Biologics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.1.3 Chronic and Autoimmune Diseases
4.1.4 Growth Hormone Deficiencies
4.1.5 Others
4.2 Global Biosimilars & Follow-on-Biologics Sales Value by Application
4.2.1 Global Biosimilars & Follow-on-Biologics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biosimilars & Follow-on-Biologics Sales Value, by Application (2019-2030)
4.2.3 Global Biosimilars & Follow-on-Biologics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biosimilars & Follow-on-Biologics Sales Value by Region
5.1.1 Global Biosimilars & Follow-on-Biologics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biosimilars & Follow-on-Biologics Sales Value by Region (2019-2024)
5.1.3 Global Biosimilars & Follow-on-Biologics Sales Value by Region (2025-2030)
5.1.4 Global Biosimilars & Follow-on-Biologics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
5.2.2 North America Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
5.3.2 Europe Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
5.4.2 Asia Pacific Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
5.5.2 South America Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
5.6.2 Middle East & Africa Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value
6.3 United States
6.3.1 United States Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.3.2 United States Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.4.2 Europe Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.5.2 China Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.6.2 Japan Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.7.2 South Korea Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.8.2 Southeast Asia Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biosimilars & Follow-on-Biologics Sales Value, 2019-2030
6.9.2 India Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biosimilars & Follow-on-Biologics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Profile
7.1.2 Novartis Main Business
7.1.3 Novartis Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.1.4 Novartis Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.1.5 Novartis Recent Developments
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Profile
7.2.2 Synthon Pharmaceuticals Main Business
7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.2.5 Synthon Pharmaceuticals Recent Developments
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Profile
7.3.2 Teva Pharmaceutical Industries Main Business
7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.3.5 LG Life Sciences Recent Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Profile
7.4.2 LG Life Sciences Main Business
7.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.4.5 LG Life Sciences Recent Developments
7.5 Celltrion
7.5.1 Celltrion Profile
7.5.2 Celltrion Main Business
7.5.3 Celltrion Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.5.4 Celltrion Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.5.5 Celltrion Recent Developments
7.6 Biocon
7.6.1 Biocon Profile
7.6.2 Biocon Main Business
7.6.3 Biocon Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.6.4 Biocon Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.6.5 Biocon Recent Developments
7.7 Hospira
7.7.1 Hospira Profile
7.7.2 Hospira Main Business
7.7.3 Hospira Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.7.4 Hospira Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.7.5 Hospira Recent Developments
7.8 Merck Group
7.8.1 Merck Group Profile
7.8.2 Merck Group Main Business
7.8.3 Merck Group Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.8.4 Merck Group Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.8.5 Merck Group Recent Developments
7.9 Biogen idec, Inc.
7.9.1 Biogen idec, Inc. Profile
7.9.2 Biogen idec, Inc. Main Business
7.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.9.5 Biogen idec, Inc. Recent Developments
7.10 Genentech (Roche Group)
7.10.1 Genentech (Roche Group) Profile
7.10.2 Genentech (Roche Group) Main Business
7.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Products, Services and Solutions
7.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2019-2024)
7.10.5 Genentech (Roche Group) Recent Developments
8 Industry Chain Analysis
8.1 Biosimilars & Follow-on-Biologics Industrial Chain
8.2 Biosimilars & Follow-on-Biologics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biosimilars & Follow-on-Biologics Sales Model
8.5.2 Sales Channel
8.5.3 Biosimilars & Follow-on-Biologics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Hospira
Novartis
Celltrion
Biocon Ltd.
Merck Group
Biogen idec Inc.
Genentech (Roche Group)
List of Tables
    Table 1. Biosimilars & Follow-on-Biologics Market Trends
    Table 2. Biosimilars & Follow-on-Biologics Market Drivers & Opportunity
    Table 3. Biosimilars & Follow-on-Biologics Market Challenges
    Table 4. Biosimilars & Follow-on-Biologics Market Restraints
    Table 5. Global Biosimilars & Follow-on-Biologics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biosimilars & Follow-on-Biologics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biosimilars & Follow-on-Biologics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biosimilars & Follow-on-Biologics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biosimilars & Follow-on-Biologics
    Table 10. Global Biosimilars & Follow-on-Biologics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biosimilars & Follow-on-Biologics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biosimilars & Follow-on-Biologics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biosimilars & Follow-on-Biologics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biosimilars & Follow-on-Biologics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biosimilars & Follow-on-Biologics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biosimilars & Follow-on-Biologics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biosimilars & Follow-on-Biologics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biosimilars & Follow-on-Biologics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biosimilars & Follow-on-Biologics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biosimilars & Follow-on-Biologics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biosimilars & Follow-on-Biologics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biosimilars & Follow-on-Biologics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novartis Basic Information List
    Table 32. Novartis Description and Business Overview
    Table 33. Novartis Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Novartis (2019-2024)
    Table 35. Novartis Recent Developments
    Table 36. Synthon Pharmaceuticals Basic Information List
    Table 37. Synthon Pharmaceuticals Description and Business Overview
    Table 38. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Synthon Pharmaceuticals (2019-2024)
    Table 40. Synthon Pharmaceuticals Recent Developments
    Table 41. Teva Pharmaceutical Industries Basic Information List
    Table 42. Teva Pharmaceutical Industries Description and Business Overview
    Table 43. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Teva Pharmaceutical Industries (2019-2024)
    Table 45. Teva Pharmaceutical Industries Recent Developments
    Table 46. LG Life Sciences Basic Information List
    Table 47. LG Life Sciences Description and Business Overview
    Table 48. LG Life Sciences Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of LG Life Sciences (2019-2024)
    Table 50. LG Life Sciences Recent Developments
    Table 51. Celltrion Basic Information List
    Table 52. Celltrion Description and Business Overview
    Table 53. Celltrion Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Celltrion (2019-2024)
    Table 55. Celltrion Recent Developments
    Table 56. Biocon Basic Information List
    Table 57. Biocon Description and Business Overview
    Table 58. Biocon Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Biocon (2019-2024)
    Table 60. Biocon Recent Developments
    Table 61. Hospira Basic Information List
    Table 62. Hospira Description and Business Overview
    Table 63. Hospira Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Hospira (2019-2024)
    Table 65. Hospira Recent Developments
    Table 66. Merck Group Basic Information List
    Table 67. Merck Group Description and Business Overview
    Table 68. Merck Group Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Merck Group (2019-2024)
    Table 70. Merck Group Recent Developments
    Table 71. Biogen idec, Inc. Basic Information List
    Table 72. Biogen idec, Inc. Description and Business Overview
    Table 73. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Biogen idec, Inc. (2019-2024)
    Table 75. Biogen idec, Inc. Recent Developments
    Table 76. Genentech (Roche Group) Basic Information List
    Table 77. Genentech (Roche Group) Description and Business Overview
    Table 78. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Biosimilars & Follow-on-Biologics Business of Genentech (Roche Group) (2019-2024)
    Table 80. Genentech (Roche Group) Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Biosimilars & Follow-on-Biologics Downstream Customers
    Table 84. Biosimilars & Follow-on-Biologics Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biosimilars & Follow-on-Biologics Product Picture
    Figure 2. Global Biosimilars & Follow-on-Biologics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biosimilars & Follow-on-Biologics Report Years Considered
    Figure 5. Global Biosimilars & Follow-on-Biologics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilars & Follow-on-Biologics Revenue in 2023
    Figure 7. Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Human Growth Hormone Picture
    Figure 9. Erythropoietin Picture
    Figure 10. Monoclonal Antibodies Picture
    Figure 11. Insulin Picture
    Figure 12. Interferon Picture
    Figure 13. Granulocyte-Colony Stimulating Factor Picture
    Figure 14. Peptide Picture
    Figure 15. Others Picture
    Figure 16. Global Biosimilars & Follow-on-Biologics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Biosimilars & Follow-on-Biologics Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Product Picture of Blood Disorders
    Figure 19. Product Picture of Oncology Diseases
    Figure 20. Product Picture of Chronic and Autoimmune Diseases
    Figure 21. Product Picture of Growth Hormone Deficiencies
    Figure 22. Product Picture of Others
    Figure 23. Global Biosimilars & Follow-on-Biologics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Biosimilars & Follow-on-Biologics Sales Value Market Share by Application, 2023 & 2030
    Figure 25. North America Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Biosimilars & Follow-on-Biologics Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Biosimilars & Follow-on-Biologics Sales Value (%), (2019-2030)
    Figure 36. United States Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 37. United States Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 38. United States Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 39. Europe Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Europe Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 41. Europe Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 42. China Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 43. China Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 44. China Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 45. Japan Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Japan Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 47. Japan Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 48. South Korea Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 49. South Korea Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 50. South Korea Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 51. Southeast Asia Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Southeast Asia Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 53. Southeast Asia Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 54. India Biosimilars & Follow-on-Biologics Sales Value, (2019-2030) & (US$ Million)
    Figure 55. India Biosimilars & Follow-on-Biologics Sales Value by Type (%), 2023 VS 2030
    Figure 56. India Biosimilars & Follow-on-Biologics Sales Value by Application (%), 2023 VS 2030
    Figure 57. Biosimilars & Follow-on-Biologics Industrial Chain
    Figure 58. Biosimilars & Follow-on-Biologics Manufacturing Cost Structure
    Figure 59. Channels of Distribution (Direct Sales, and Distribution)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Global TNF IL Cytokines Market Insights Forecast to 2030
Global Bio Similars Subsequent Entry Biologic Market Research Report 2024
Biopharma Track and Trace Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Marine Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bevacizumab Biosimilar Market
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-22Z9081
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global 4-Nitroanisole Reagent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3W15696
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global GC and GC-MS Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-7K9415
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Global Pentamidine Isethionate Reagent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1M15643
Fri Apr 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions
OSZAR »